The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
This randomized, double-blind, placebo-controlled trial beautifully demonstrated the powerful benefits of grape seed extract (GSE) supplementation in improving several key metabolic and liver health parameters in individuals with non-alcoholic fatty liver disease (NAFLD). Over the course of two months, participants who took 520 mg of GSE daily experienced impressively significant
June 26, 2025
No Comments